Goldman Sachs signed a letter of intent to invest US$40 million in Chinese drug retailer Shenzhen Nep-Star Medical Co, Beijing Business Day reported. Nep-Star, billed as China's sixth largest medicine company, said the money would fund business expansion, much of that focused on extending the company's chain of drugstores.
You must log in to post a comment.
Yes, I would like to receive emails from China Economic Review. (You can unsubscribe anytime)
Copyright © 2018 SinoMedia Group Limited All rights reserved